Oxford Industries, Inc. (OXM) Tops Q3 EPS by 2c, Offers Strong Q4, FY11 Guidance
Tweet
Share
E-mailGet Alerts OXM Hot Sheet
Price: $36.37 +0.17%
Revenue Growth %: -2.4%
Financial Fact:
Diluted (in shares): 16.53M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Revenue Growth %: -2.4%
Financial Fact:
Diluted (in shares): 16.53M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Oxford Industries, Inc. (NYSE: OXM) reported Q3 EPS of $0.16, $0.02 better than the analyst estimate of $0.14. Revenue for the quarter came in at $170.3 million versus the consensus estimate of $164.92 million.
Oxford Industries, Inc. sees FY2011 EPS of $2.30-$2.35, versus prior guidance of $2.20-$2.30 and the consensus of $2.27. Oxford Industries, Inc. sees FY2011 revenue of $745-$755 million, versus prior guidance of $735-$750 million and the consensus of $738.14 million.
Oxford Industries, Inc. sees Q4 2011 EPS of $0.50-$0.55, versus the consensus of $0.48. Oxford Industries, Inc. sees Q4 2011 revenue of $185-$195 million, versus the consensus of $184 million.
Oxford Industries, Inc. sees FY2011 EPS of $2.30-$2.35, versus prior guidance of $2.20-$2.30 and the consensus of $2.27. Oxford Industries, Inc. sees FY2011 revenue of $745-$755 million, versus prior guidance of $735-$750 million and the consensus of $738.14 million.
Oxford Industries, Inc. sees Q4 2011 EPS of $0.50-$0.55, versus the consensus of $0.48. Oxford Industries, Inc. sees Q4 2011 revenue of $185-$195 million, versus the consensus of $184 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
